U.S. Physical Therapy (USPH) Stock Overview
Operates and manages outpatient physical therapy clinics. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
USPH Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
U.S. Physical Therapy, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$62.50 |
| 52 Week High | US$93.50 |
| 52 Week Low | US$58.19 |
| Beta | 1.2 |
| 1 Month Change | -12.99% |
| 3 Month Change | -25.67% |
| 1 Year Change | -15.52% |
| 3 Year Change | -42.37% |
| 5 Year Change | -47.90% |
| Change since IPO | 2,486.20% |
Recent News & Updates
USPH: Hospital Alliances And Medicare Pricing Will Drive Future Margin Recovery
Analysts have trimmed their blended price target on U.S. Physical Therapy from about $107 to roughly $94, reflecting lower P/E assumptions and somewhat softer profitability expectations, along with higher net debt. They also note potential margin improvement supported by hospital alliances and improved Medicare rates.U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking AlphaRecent updates
Shareholder Returns
| USPH | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0.6% | -0.3% | 1.2% |
| 1Y | -15.5% | 11.8% | 27.0% |
Return vs Industry: USPH underperformed the US Healthcare industry which returned 12.5% over the past year.
Return vs Market: USPH underperformed the US Market which returned 28.2% over the past year.
Price Volatility
| USPH volatility | |
|---|---|
| USPH Average Weekly Movement | 7.0% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: USPH has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: USPH's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 6,374 | Chris Reading | www.usph.com |
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
U.S. Physical Therapy, Inc. Fundamentals Summary
| USPH fundamental statistics | |
|---|---|
| Market cap | US$951.63m |
| Earnings (TTM) | US$7.67m |
| Revenue (TTM) | US$787.69m |
Is USPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| USPH income statement (TTM) | |
|---|---|
| Revenue | US$787.69m |
| Cost of Revenue | US$615.17m |
| Gross Profit | US$172.52m |
| Other Expenses | US$164.85m |
| Earnings | US$7.67m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.50 |
| Gross Margin | 21.90% |
| Net Profit Margin | 0.97% |
| Debt/Equity Ratio | 26.2% |
How did USPH perform over the long term?
See historical performance and comparisonDividends
Does USPH pay a reliable dividends?
See USPH dividend history and benchmarks| U.S. Physical Therapy dividend dates | |
|---|---|
| Ex Dividend Date | May 22 2026 |
| Dividend Pay Date | Jun 12 2026 |
| Days until Ex dividend | 13 days |
| Days until Dividend pay date | 8 days |
Does USPH pay a reliable dividends?
See USPH dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/02 12:30 |
| End of Day Share Price | 2026/06/02 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
U.S. Physical Therapy, Inc. is covered by 15 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Joseph France | Cantor Fitzgerald & Co. |